The scrutiny follows a critical report from Jehoshaphat Research, which questioned the company’s sales practices and accounting transparency. The research firm, which disclosed a short position in the Canadian manufacturer, argued that Gildan’s reported revenue growth masked an underlying decline that had persisted for years. Following the release of these findings, the company's NYSE-listed stock faced an immediate and significant market correction.

Rosen Law is now soliciting shareholders to join a prospective class action lawsuit to recover losses related to these disclosures. The firm, led by Laurence Rosen and Phillip Kim, emphasizes that investors may participate in the litigation via a contingency fee arrangement, requiring no upfront costs. Interested parties are encouraged to contact the firm’s New York office as the investigation into potential securities violations continues.